Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvin Kamili

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Atherosclerosis|January 23, 2009
Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat dietElaine Wat, Sally Tandy, Ewa Kapera, et al.
The Journal of Biological Chemistry|November 24, 2006
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generationWoojin Scott Kim, Aldwin Suryo Rahmanto, Alvin Kamili, et al.
Plos One|February 15, 2013
Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed miceRosanna W S Chung, Alvin Kamili, Sally Tandy, et al.
Journal of Cell Science|July 18, 2015
TPD52 expression increases neutral lipid storage within cultured cellsAlvin Kamili, Nuruliza Roslan, Sarah Frost, et al.
International Journal of Cancer|February 23, 2020
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastomaAndrew E Tee, Olivia C Ciampa, Matthew Wong, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastomaHolly Holliday, Jessica Yang, Eoin Dodson, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Atherosclerosis|January 23, 2009
Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat dietElaine Wat, Sally Tandy, Ewa Kapera, et al.
The Journal of Biological Chemistry|November 24, 2006
Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-beta peptide generationWoojin Scott Kim, Aldwin Suryo Rahmanto, Alvin Kamili, et al.
Plos One|February 15, 2013
Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed miceRosanna W S Chung, Alvin Kamili, Sally Tandy, et al.
Journal of Cell Science|July 18, 2015
TPD52 expression increases neutral lipid storage within cultured cellsAlvin Kamili, Nuruliza Roslan, Sarah Frost, et al.
International Journal of Cancer|February 23, 2020
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastomaAndrew E Tee, Olivia C Ciampa, Matthew Wong, et al.
Biochemical Pharmacology|December 22, 2019
CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growthTony Huynh, Jayne Murray, Claudia L Flemming, et al.
Cancer Research|July 12, 2020
Suppression of ABCE1-Mediated mRNA Translation Limits N-MYC-Driven Cancer ProgressionJixuan Gao, MoonSun Jung, Chelsea Mayoh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 9, 2022
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastomaHolly Holliday, Jessica Yang, Eoin Dodson, et al.
British Journal of Cancer|January 11, 2020
Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyAlvin Kamili, Andrew J Gifford, Nancy Li, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Pageof 4